GES-type and OXA-23 carbapenemase-producing Acinetobacter baumannii in Turkey

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 4, 2014, Pages 1145-1146

  Zeka, Arzu Nazli ^a,b   Poirel, Laurent ^a,c   Sipahi, Oguz Resat ^b   Bonnin, Rémy A ^a   Arda, Bilgin ^b   Özinel, Memetali ^b   Ulusoy, Sercan ^b   Bor, Canan ^b   Nordmann, Patrice ^a,c  

^a Associated French National Reference Center for Antibiotic Resistance: Carbapenemase producing Enterobacteriaceae   (France)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c University of Fribourg   (Switzerland)

Author keywords

A. baumannii; GES 11; lactamases

Indexed keywords

AMIKACIN; CARBAPENEM; CEFTRIAXONE; COLISTIN; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; NETILMICIN; TIGECYCLINE; TRIMETHOPRIM;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; APACHE; BACTEREMIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; DISK DIFFUSION; FEMALE; GES 11 GENE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; OXA 23 GENE; TURKEY (REPUBLIC); VENTILATOR ASSOCIATED PNEUMONIA; VERY ELDERLY;

A. BAUMANNII; GES-11; Β-LACTAMASES;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; TURKEY;

EID: 84896477429     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt465     Document Type: Letter

References (9)

1. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12: 826-36.
2. Bonnin RA, Nordmann P, Potron A et al. Carbapenem-hydrolyzing GES-type extended-spectrum β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2011; 55: 349-54.
3. Bonnin RA, Rotimi VO, Al Hubail M et al. Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait. Antimicrob Agents Chemother 2013; 57: 183-8.
4. BogaertsP,NaasT, El Garch Fet al.GESextended-spectrumβ-Lactamases in Acinetobacter baumannii isolates in Belgium. Antimicrob Agents Chemother 2010; 54: 4872-8.
5. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-third Informational Supplement M100-S23. CLSI,Wayne, PA, USA, 2013.
6. Moubareck C, Brémont S, Conroy MC et al. GES-11, a novel integronassociated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother 2009; 53: 3579-81.
7. Bertini A, Poirel L, Mugnier PD et al. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother 2010; 54: 4168-77.
8. Diancourt L, Passet V, Nemec A et al. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 2010; 5: e10034.
9. Cicek AC, Saral A, Iraz M et al. OXA-and GES-type β-Lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin Microbiol Infect 2013; doi:10.1111/1469-0691.12338.